Synthesis of chromone-indole derivatives and evaluation of their antitumor activity
Bioorganic Chemistry · 2026-07 · 175 · 109809
DOI: 10.1016/j.bioorg.2026.109809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-07. Verfasst von Ling-Rong Zeng und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China. Hauptthemen laut MEDLINE: Indoles, Antineoplastic Agents, Chromones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: State Key Laboratory of Natural and Biomimetic Drugs, Natural Science Research Project of Guizhou Province, National Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Cancer remains a major global health threat, creating an urgent demand for new, selective small-molecule anticancer agents. To address the paucity of potent, targeted chromone-derived antitumor compounds and fill the knowledge gap in C-2 modified chromone-indole hybrids, we designed, synthesized, and biologically evaluated 24 novel chromone-indole hybrids via C-2 modification of the chromone core and conjugation with indole. All compounds were characterized by 1H NMR, 13C NMR and High-resolution mass spectrometry (HRMS), with single-crystal X-ray diffraction for compound 3 k. In vitro Cell Counting Kit-8 (CCK-8) assays (cisplatin as positive control) identified several potent and selective antiproliferative agents: 3q (IC50 = 14.05 ± 0.95 μM, K562), 3m (IC50 = 13.95 ± 0.98 μM, HeLa) and notably 3h (IC50 = 6.70 ± 0.37 μM, AGS). Network pharmacology and PPI analysis identified MDM2, MAPK1, PGR and AR as core targets; molecular docking confirmed stable binding via hydrogen bonds, π -π stacking and halogen interactions. Label-free surface plasmon resonance(SPR)assays verified direct binding of 3 h to Progesterone receptor (PGR) (KD = 2.41 × 10-6 M; ka = 70.07 × 103 M-1·s-1, kd = 16.87 × 10-2 s-1, τ = 5.93 s), confirming target engagement.Collectively, this study addresses critical gaps in chromone-indole hybrid research, provides an efficient synthetic strategy, and identifies 3 h as a promising lead candidate for further optimization and in vivo studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
- College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China; State Key Laboratory of Natural and Biomimetic Drugs, Beijing 100191, China; Guizhou Key Laboratory of Modern Traditional C…
- College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China; Guizhou Key Laboratory of Modern Traditional Chinese Medicine Creation, Guiyang 550025, China. Electronic address: ftt0809@…
- College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China; Guizhou Key Laboratory of Modern Traditional Chinese Medicine Creation, Guiyang 550025, China. Electronic address: yingzhou…
- College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China; Guizhou Key Laboratory of Modern Traditional Chinese Medicine Creation, Guiyang 550025, China. Electronic address: bwpan110…
Förderung
- State Key Laboratory of Natural and Biomimetic Drugs
- Natural Science Research Project of Guizhou Province
- National Administration of Traditional Chinese Medicine
- Guizhou University
- University of Science and Technology Beijing State Key Laboratory for Advanced Metals and Materials
- Dalian High-Level Talent Innovation Program
Zitieren
APA
Zeng, L. R., Shi, Y., Liu, J., Dong, Z. C., Feng, T. T., Zhou, Y., & Pan, B. W. (2026). Synthesis of chromone-indole derivatives and evaluation of their antitumor activity. Bioorganic Chemistry, 175, 109809. https://doi.org/10.1016/j.bioorg.2026.109809
Vancouver
Zeng LR, Shi Y, Liu J, Dong ZC, Feng TT, Zhou Y, et al. Synthesis of chromone-indole derivatives and evaluation of their antitumor activity. Bioorganic Chemistry. 2026;175:109809. doi:10.1016/j.bioorg.2026.109809
BibTeX
@article{Zeng2026,
author = {Zeng, Ling-Rong and Shi, Yang and Liu, Jin and Dong, Zhang-Chao and Feng, Ting-Ting and Zhou, Ying and Pan, Bo-Wen},
title = {Synthesis of chromone-indole derivatives and evaluation of their antitumor activity},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {175},
pages = {109809},
doi = {10.1016/j.bioorg.2026.109809}
}
EUVIMED